Astrazeneca AZN
NYSE AZN
$171.52 -1.05 (-0.61%)
As of: Oct 23, 2026 · 3:59 PM EDT

Astrazeneca (AZN) Free Cash Flow (2009 - 2026)

Updated

Astrazeneca (AZN) posted Free Cash Flow of $5.34 billion for Q2 2026, down 1.7% from $5.43 billion a year earlier but up 9.6% from the prior quarter.

Analysis

Astrazeneca (AZN) Free Cash Flow (2009 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Free Cash Flow at Astrazeneca was $21.4 billion, up 7.5% year-over-year; for FY2025, it came in at $21.55 billion, up 20.7% from FY2024.

  • Annual Free Cash Flow has increased for seven consecutive years, with a five-year compound annual growth rate of 21.7% (FY2020 to FY2025).
  • In prior years, Astrazeneca's Free Cash Flow was $17.85 billion in FY2024 (+17.8%), $15.15 billion in FY2023 (+13.3%), $13.37 billion in FY2022 (+40.5%) and $9.52 billion in FY2021 (+18.2%).
  • Quarterly Free Cash Flow has run from a low of $2.47 billion in Q2 2022 to a high of $6.91 billion in Q3 2025 over five years.
  • On a year-over-year basis, Free Cash Flow has declined in each of the last three quarters, with growth averaging 13.6% over the last six quarters.
  • The strongest year-over-year quarter for Free Cash Flow in the past five years was Q2 2024, with growth of 51.3%; the weakest was Q4 2021, with a decline of 8.6%.
  • According to Business Quant data, Free Cash Flow for the three prior quarters was $4.87 billion (Q1 2026), $4.28 billion (Q4 2025) and $6.91 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 7.76 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 6.36 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 3.11 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 4.48 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 5.56 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 1.01 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 3.49 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.43 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 302.00 Mn
10 Vertex Pharmaceuticals 133.09 Bn 105.09 Bn 2.84 Bn 1.01 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.01 Bn
Mar 31, 2026 3.91 Bn
Dec 31, 2025 -2.24 Bn
Sep 30, 2025 8.00 Bn
Jun 30, 2025 1.87 Bn
Mar 31, 2025 4.14 Bn
Dec 31, 2024 -233.00 Mn
Sep 30, 2024 5.40 Bn
Jun 30, 2024 1.87 Bn
Mar 31, 2024 2.90 Bn
Jun 30, 2023 954.00 Mn
Mar 31, 2023 3.38 Bn
Jun 30, 2022 557.00 Mn
Mar 31, 2022 3.45 Bn
Dec 31, 2021 -441.00 Mn
Sep 30, 2021 3.00 Bn
Jun 30, 2021 164.00 Mn
Mar 31, 2021 2.15 Bn
Dec 31, 2020 239.00 Mn
Sep 30, 2020 2.79 Bn
API Access

Astrazeneca Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=AZN&period=max&api_key=YOUR_API_KEY